论文部分内容阅读
Aim The present study aimed to evaluate the outcomes of haplo-HSCT in adult Ph-negative ALLCR1 patients.Methods The present study included 183 consecutive Ph-negative ALL patients receiving their firstallogeneic HSCT in CR1 from a haplo-RD.Results Three-year incidences of relapse and nonrelapse mortality for high-risk versus low-riskgroups were 15.4% versus 17.8% (P = 0.641) and 18.0% versus 16.2% (P = 0.717),respectively.